Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cancer
Clinical trial register · France

Cancer Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9714 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
9714
Studies in scope
all four open statuses
6038
Recruiting now
open to new participants
1027
Lead sponsors
across recruiting studies
Top sites
Lyon 17 Paris 16 Lille 12 Brest 9 Bordeaux 9
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospices Civils de Lyon10 Institut Curie5 University Hospital, Brest4 Assistance Publique - Hôpitaux de Paris4 Institut du Cancer de Montpellier - Val d'Aurelle4 Hoffmann-La Roche3 Gustave Roussy, Cancer Campus, Grand Paris2 University Hospital, Toulouse2 Centre Hospitalier Universitaire de Saint Etienne2 AstraZeneca2 Centre Hospitalier Universitaire, Amiens2 Centre Georges Francois Leclerc2 Ribocure Pharmaceuticals AB1 Centre Hospitalier Universitaire de Nīmes1 Institut Bergonié1 Centre Oscar Lambret1 University Hospital, Caen1 University Hospital, Strasbourg, France1 Hôpital NOVO1 Alterome Therapeutics, Inc.1 Poitiers University Hospital1 Lille University1 University Hospital, Clermont-Ferrand1 Institut Rafael1 Centre Hospitalier Emile Roux1 Show all 50
Site location
Lyon17 Paris16 Lille12 Brest9 Bordeaux9 Dijon9 Montpellier9 Marseille8 Pierre-Bénite8 Villejuif7 Clermont-Ferrand7 Caen6 Nice5 Besançon5 Vandœuvre-lès-Nancy5 Grenoble4 Nantes4 Rennes4 Saint-Herblain4 Toulouse4 Tours3 Reims3 Saint-Cloud3 Bron3 Amiens3 Show all 60
All 60 locations
Target enrolment
to

Cancer trials in France

80 of 9714 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Vortosiran for VTE Prevention
NCT07850453Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
DrugVortosiran
Ribocure Pharmaceuticals AB
Phase 2
150
Chambray-lès-Tours, Colombes, Grenoble, Paris
2026-10
Not yet open
Centre Oscar Lambret
Not applicable
493
Lille
2026-10
Not yet open
Centre Hospitalier Universitaire, Amiens
Not applicable
84
Amiens
2026-10
Not yet open
Celtic Biotech Ltd
Phase 1
24
Saint-Herblain
2026-10
Recruiting
Institut Rafael
Not applicable
80
Levallois-Perret
2026-09-30
Not yet open
Physical Exercise During the Cancer Care Pathway
NCT07652502Cancer, Treatment-Related, Cancer, Oncology, Oncologic Disorders
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
370
Paris
2026-06-15
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
50
Nîmes
2026-06-02
Recruiting
Hôpital NOVO
Observational
20
Cergy-Pontoise
2026-04-21
By invitation
ADN Fœtal Circulant, Grossesse et Pathologies Malignes
NCT07448025Femmes Enceintes, Cancer
Assistance Publique - Hôpitaux de Paris
Observational
300
Clamart
2026-04-15
Recruiting
Pharmaceutical Management in Targeted Radioligand Therapy
NCT07389512Cancer, Thyroid Cancer, Metastatic Prostate Cancer, Neuroendocrine Tumor Carcinoid
Hospices Civils de Lyon
Observational
600
Bron, Dijon, Lille
2026-01-09
Recruiting
Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer
NCT07280416Cancer, Insomnia, Pain, Depression Anxiety Disorder
Centre Hospitalier Emile Roux
Observational
260
Le Puy-en-Velay
2025-12-16
Recruiting
University Hospital, Brest
Not applicable
96
Brest, Morlaix, Quimper
2025-11-21
Recruiting
Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous
NCT07210671Superficial Vein Thrombosis, Cancer, Venous Thrombosis
Centre Hospitalier Universitaire, Amiens
Observational
1,576
Amiens
2025-11-10
Recruiting
Cancer-related Venous Thromboembolic Disease - Cohort Study
NCT06393764Thrombosis Embolism, Thromboses, Venous, Cancer
University Hospital, Brest
Observational
150
Brest
2025-10-30
Recruiting
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
NCT07060950Cancer, Lung Cancer, Non-Small Cell
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
620
Montpellier
2025-09-26
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
212
Clermont-Ferrand, Grenoble, Lyon, Saint-Etienne
2025-09-02
Recruiting
Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital.
NCT07560423Patient Satisfaction, Cancer, Quality of Health Care
Centre Hospitalier de Martigues
Observational
309
Martigues
2025-07-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
3,149
Lyon, Paris
2025-07-01
Recruiting
Hospices Civils de Lyon
Observational
3,000
Pierre-Bénite
2025-06-23
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
60
Saint-Etienne
2025-06-13
Recruiting
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NCT06829719Infection, Cancer, Rejection, Kidney Transplantation
DrugBiological tests
Hospices Civils de Lyon
Not applicable
600
Bordeaux (France), Lyon, Strasbourg (france), Toulouse (France)
2025-04-23
Recruiting
Hôpital Européen Marseille
Not applicable
168
Marseille
2025-04-22
Recruiting
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
NCT06332274Cancer, Lung Cancer, Colo-rectal Cancer, Pancreas Cancer
DrugTislelizumab
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
717
Villejuif
2025-04-16
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
2,000
Paris
2025-04-12
Recruiting
Lille University
Observational
350
Lille
2025-04-02
Recruiting
Resilience
Phase 3
1,458
Aix-en-Provence, Aurillac, Bayonne, Caen, Clermont-Ferrand, La Tronche, Lille, Lyon
2025-04-01
Not yet open
Hospices Civils de Lyon
Not applicable
720
Lyon
2025-03-15
Recruiting
Hospices Civils de Lyon
Observational
100
Pierre-Bénite
2025-02-10
Recruiting
Hospices Civils de Lyon
Not applicable
55
Pierre-Bénite
2025-02-10
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Lyon, Toulouse, Villejuif
2024-11-07
Recruiting
Vulnerability and Risk of Neuropathic Pain in Cancer
NCT06511674Neuropathic Pain, Cancer, Predictive
University Hospital, Clermont-Ferrand
Not applicable
625
Ajaccio, Angers, Aurillac, Bordeaux, Caen, Clermont-Ferrand, Colmar, Dijon
2024-10-28
Active, closed
Description of the Stroma of Solid Tumors (DISTRO)
NCT07396740Cancer, Benign Tumors
University Hospital, Brest
Observational
7,000
Brest
2024-09-18
Active, closed
Centre Leon Berard
Not applicable
240
Lyon, Montpellier, Paris, Saint-Cloud, Vandœuvre-lès-Nancy, Villejuif
2024-09-12
Recruiting
University Hospital, Toulouse
Not applicable
350
Nancy, Toulouse
2024-08-30
Active, closed
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT06533059Cancer, Breast Cancer, Endometrial Cancer, Metastatic Cancer
Alterome Therapeutics, Inc.
Phase 1
110
Caen, Villejuif
2024-08-22
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
55
Montpellier
2024-06-18
Recruiting
Centre Hospitalier Intercommunal Creteil
Observational
66
Créteil
2024-04-10
Active, closed
Management of Bone Metastases
NCT06713941Cancer, Bone Metastases
Hospices Civils de Lyon
Observational
900
Brest, Lyon
2024-03-15
Recruiting
University Hospital, Brest
Observational
200
Brest
2024-02-09
Active, closed
Institut de Cancérologie de Lorraine
Not applicable
52
Vandœuvre-lès-Nancy
2024-01-04
Recruiting
Centre Hospitalier de Valenciennes
Not applicable
289
Valenciennes
2023-12-12
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
500
Avignon
2023-10-18
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
450
Paris
2023-10-01
Recruiting
University Hospital, Rouen
Observational
1,000
Caen, Lille
2023-09-01
Recruiting
Institut Curie
Not applicable
50
Paris, Suresnes
2023-08-03
Recruiting
Hoffmann-La Roche
Phase 3
200
Marseille, Bordeaux, Caen, Dijon, Lyon, Montpellier, Nantes, Nîmes
2023-06-01
Active, closed
AstraZeneca
Phase 3
37
Villejuif
2023-05-08
Recruiting
Institut Curie
Not applicable
50
Tours, Avignon, Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier
2023-04-08
Active, closed
University Hospital, Strasbourg, France
Not applicable
200
Lyon, Nantes, Nice, Reims, Strasbourg, Marseille, Rennes, Saint-Herblain
2023-04-04
Recruiting
Poitiers University Hospital
Not applicable
60
Poitiers
2022-10-13
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
2022-10-04
Active, closed
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
NCT05563883Atrial Fibrillation, Cancer, Thromboembolism, Bleeding
University Hospital, Caen
Observational
5,000,000
Tours
2022-09-22
Recruiting
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
NCT05318196Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation, Cancer
University Hospital, Toulouse
Observational
5,000
Toulouse
2022-09-05
Recruiting
Institut Curie
Not applicable
300
Paris, Saint-Cloud
2022-08-31
Recruiting
Médipôle Lyon-Villeurbanne
Not applicable
104
Villeurbanne
2022-08-16
Recruiting
Institut Curie
Not applicable
2,050
Paris, Saint-Cloud
2022-05-19
By invitation
AstraZeneca
Phase 3
214
Besançon, Bordeaux, Brest, Dijon, Lyon, Marseille, Montpellier, Rennes
2022-04-19
Recruiting
Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
NCT05799898Cancer, Immune Checkpoint Inhibitor, Cardiovascular Complication, Immune-related Adverse Event
Institut Mutualiste Montsouris
Observational
200
Paris
2022-03-01
Recruiting
University Hospital, Lille
Observational
700
Lille
2021-02-18
Active, closed
Bayer
Phase 3
774
Clermont-Ferrand, Pierre-Bénite, Dijon, Brest, Rennes, Tours, Reims, Bordeaux
2020-10-20
Recruiting
Centre Georges Francois Leclerc
Phase 2
7,976
Amiens, Besançon, Bordeaux, Caen, Dijon, Levallois-Perret, Lille, Nantes
2020-08-25
Recruiting
Centre Antoine Lacassagne
Observational
40,000
Nice
2020-01-07
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
600
Montpellier
2019-11-25
Active, closed
Institut Curie
Observational
690
Paris, Vandœuvre-lès-Nancy
2019-11-15
Recruiting
Centre Georges Francois Leclerc
Not applicable
613
Besançon, Dijon, Reims, Troyes
2019-10-07
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bordeaux, Vandœuvre-lès-Nancy, Clermont-Ferrand, Créteil, Dijon, La Tronche, Lille, Marseille
2019-08-09
Recruiting
Hospices Civils de Lyon
Observational
2,000
Bron, Lyon, Pierre-Bénite
2019-07-15
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Brest
2019-06-24
Recruiting
Hospices Civils de Lyon
Not applicable
248
Pierre-Bénite
2019-06-18
Active, closed
AbbVie
Phase 1
150
Saint-Herblain, Paris, Lyon, Clermont-Ferrand
2019-05-21
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Angers, Nice, Lille, Marseille, Villejuif
2019-02-28
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Besançon, Brest, Lille, Vandœuvre-lès-Nancy, Bordeaux, Saint-Herblain, Marseille
2019-01-04
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
1,240
Villejuif, Chevilly-Larue, Le Kremlin-Bicêtre, Le Plessis-Robinson
2018-12-12
Recruiting
Hospices Civils de Lyon
Not applicable
410
Bron, Lyon, Pierre-Bénite
2018-12-04
Recruiting
Analysis of Circulating Tumor Markers in Blood
NCT04025541Cancer, Breast Cancer, Sarcoma, Lung Cancers
DrugBlood sampling
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
992
Montpellier
2018-05-29
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Recruiting
Cardio-Oncology Registry
NCT04407780Cancer, Cardiac Disease, Metabolic Syndrome, Arrhythmia
European Georges Pompidou Hospital
Observational
5,000
Paris
2017-01-01
Active, closed
Institut Bergonié
Observational
265
Bordeaux, Dijon, Montpellier
2009-09
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Paris
2005-08
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
—
Nice
2005-01-01
Rows per page Showing 1–80 of 80
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-france/condition/cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 80 of those studies listing the condition Cancer.

How many Cancer trials are recruiting in France?

56 of the 80 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 16 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cancer), 80 studies
PhaseStudiesRecruitingShare
Not applicable322540%
Observational322540%
Phase 38310%
Phase 1415%
Phase 2425%

Most active sponsors

Lead sponsors with the most studies (Cancer)
Lead sponsorStudiesRecruiting
Hospices Civils de Lyon108
Institut Curie54
Assistance Publique - Hôpitaux de Paris43
Institut du Cancer de Montpellier - Val d'Aurelle44
University Hospital, Brest43
Hoffmann-La Roche31
AstraZeneca20
Centre Georges Francois Leclerc22
Centre Hospitalier Universitaire de Saint Etienne22
Centre Hospitalier Universitaire, Amiens21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.